Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV004699394 | SCV005205613 | uncertain significance | Hereditary thrombocytopenia and hematologic cancer predisposition syndrome | 2024-09-12 | reviewed by expert panel | curation | NM_001754.5(RUNX1):c.352-12_352-9del is an intronic deletion outside of the typical splicing region. It is not predicted to impact splicing, with a SpliceAI score ≤ 0.20 (0.01) (BP4). This variant is completely absent from all population databases with at least 20x coverage for RUNX1 (PM2_Supporting). In summary, the clinical significance of this variant is uncertain. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: PM2_Supporting, BP4. |
Labcorp Genetics |
RCV001479897 | SCV001684203 | likely benign | Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 | 2020-10-21 | criteria provided, single submitter | clinical testing |